Onconetix, Inc. (ONCO)
NASDAQ: ONCO · IEX Real-Time Price · USD
0.153
+0.019 (14.61%)
May 22, 2024, 4:00 PM EDT - Market closed

Onconetix Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Revenue
0.060000
Cost of Revenue
1.190000
Gross Profit
-1.130000
Selling, General & Admin
14.779.352.091.10.82
Research & Development
1.954.131.330.520.06
Other Operating Expenses
18.190000
Operating Expenses
34.9113.483.421.620.88
Operating Income
-36.03-13.48-3.42-1.62-0.88
Interest Expense / Income
0.670000
Other Expense / Income
0.72-0.06--0.02-0.06
Pretax Income
-37.42-13.42-3.42-1.6-0.82
Income Tax
-0.010000
Net Income
-37.41-13.42-3.42-1.6-0.82
Preferred Dividends
00.10.630.560.28
Net Income Common
-37.41-13.52-4.04-2.16-1.1
Shares Outstanding (Basic)
1712333
Shares Outstanding (Diluted)
1712333
Shares Change
39.44%283.48%---
EPS (Basic)
-2.19-1.10-1.26-0.67-0.34
EPS (Diluted)
-2.19-1.10-1.26-0.67-0.34
Free Cash Flow
-13.64-8.68-2.05-1.74-0.83
Free Cash Flow Per Share
-0.80-0.71-0.64-0.54-0.26
Gross Margin
-1927.93%----
Operating Margin
-61634.47%----
Profit Margin
-63986.48%----
Free Cash Flow Margin
-23323.46%----
EBITDA
-36.71-13.41-3.41-1.6-0.82
EBITDA Margin
-62784.10%----
Depreciation & Amortization
0.040.01000
EBIT
-36.75-13.42-3.42-1.6-0.82
EBIT Margin
-62859.25%----
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).